Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Neuromuscul Disord ; 32(11-12): 886-892, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36270935

RESUMO

The aim of the study was to describe the characteristics of children with neuromuscular diseases treated with long term noninvasive ventilation or continuous positive airway pressure in France. On June 1st 2019, 387 patients (63% boys, mean age 11.2 ± 5.5 years) were treated with long term noninvasive ventilation/continuous positive airway pressure. Thirty three percent of patients had spinal muscular atrophy, 30% congenital myopathy/dystrophy, 20% Duchenne muscular dystrophy, 7% Steinert myotonic dystrophy, and 9% other neuromuscular diseases. Ninety-four percent of patients were treated with long term noninvasive ventilation and 6% with continuous positive airway pressure. Treatment was initiated electively for 85% of patients, mainly on an abnormal overnight gas exchange recording (38% of patients). Noninvasive ventilation/continuous positive airway pressure was initiated during a respiratory exacerbation in 15% of patients. Mean duration of noninvasive ventilation/continuous positive airway pressure was 3.3 ± 3.1 years. Mean objective long term noninvasive ventilation/continuous positive airway pressure use was 8.0 ± 3.1 h/24. Spinal muscular atrophy, congenital myopathy/dystrophy, and Duchenne muscular dystrophy represented 83% of children with neuromuscular diseases treated with long term noninvasive ventilation in France. Screening for nocturnal hypoventilation was satisfactory as noninvasive ventilation /continuous positive airway pressure was predominantly initiated electively.


Assuntos
Atrofia Muscular Espinal , Distrofia Muscular de Duchenne , Doenças Neuromusculares , Ventilação não Invasiva , Masculino , Criança , Humanos , Pré-Escolar , Adolescente , Feminino , Pressão Positiva Contínua nas Vias Aéreas , Distrofia Muscular de Duchenne/complicações , Distrofia Muscular de Duchenne/terapia , Doenças Neuromusculares/complicações , Doenças Neuromusculares/terapia
2.
J Cyst Fibros ; 20(5): 792-795, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34417145

RESUMO

Diabetes is a comorbidity of cystic fibrosis (CF) that worsens prognosis. Abnormal glucose tolerance is associated with decreased lung function and poorer nutritional status. Data are lacking on glucose tolerance abnormalities in young children. We report three infants with abnormal glucose tolerance, beginning under the age of one year, including two cases of very early diabetes which started before the age of six months. None of our patients required long-term insulin treatment, and glycaemia spontaneously improved. All three patients had early pulmonary infection with Pseudomonas aeruginosa and poor nutritional status. This case series presents three unique patients with early dysglycaemia, then improvement over time. This adds to the understanding of the spectrum of early dysglycaemia in CF and highlights the difficulty of diagnosis in this age group.


Assuntos
Glicemia/metabolismo , Fibrose Cística/metabolismo , Fibrose Cística/fisiopatologia , Intolerância à Glucose/metabolismo , Intolerância à Glucose/fisiopatologia , Feminino , Teste de Tolerância a Glucose , Humanos , Lactente , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA